Fountain TRT AI Market Strategy Report - TRT Clinics

Answer Capsule

Fountain TRT holds a narrow recommendation pocket in the TRT Clinics category, appearing in 14.22% of qualified AI answers and earning valid recommendations in 8.72% of them during September 2026. The brand is visible but under-recommended: it surfaces in AI responses more than twice as often as it converts that presence into a clear recommendation. Its clearest win is a modest top-three placement rate of 3.21%, while its clearest weakness is a rank-one rate of just 0.46% and a 2.3-point decline in valid recommendation coverage since the July 2026 baseline. The clearest opportunity is converting existing presence into shortlist-level recommendations, particularly on Google AI Mode and Copilot, where the brand already appears but rarely converts.

Who This Report Is For

This report is for Fountain TRT leadership, marketing strategists, and category analysts tracking how testosterone replacement therapy brands are surfaced and recommended across AI and search platforms.

Report Card

Executive Summary

Fountain TRT enters September 2026 with a raw mention presence rate of 14.22% and valid recommendation coverage of 8.72% across 218 qualified AI observations in the TRT Clinics category. The gap between presence and recommendation is the defining feature of the brand's position: Fountain TRT appears in AI answers more than twice as often as it earns a clear, actionable recommendation.

The brand recorded 31 total mentions in September 2026, comprising 20 positive mentions, 11 neutral mentions, and zero negative mentions. Its net sentiment score of 0.6452 indicates that when Fountain TRT does appear, the framing is predominantly favorable. The challenge is not perception but conversion: presence is not translating into shortlist placement at competitive rates.

Fountain TRT's strongest cluster is C01, Best TRT Clinics & Top Testosterone Therapy Providers, which is the only cluster with qualified observations in the current public series. Within this consideration-stage cluster, the brand holds a top-three rate of 3.21% and a rank-one rate of 0.46%, meaning it is rarely positioned as a leading option when buyers ask AI systems for clinic recommendations.

The brand's strongest platform signal comes from Google AI Mode, where it recorded 7 valid recommendations and a positive visibility rate of 12.3%. Copilot also shows a meaningful signal with 7 valid recommendations and a top-three rate of 10.3%. However, on ChatGPT, Perplexity, and Gemini, Fountain TRT either does not appear or appears only as context without recommendation credit.

The clearest platform gap is Gemini, where Fountain TRT recorded 3 context-only mentions across 20 observations. Perplexity also shows a minimal footprint, with 2 positive mentions across 6 observations but no recommendation-level conversion. These absences represent unaddressed surfaces where competitors like Hone Health, Defy Medical, and Maximus are actively earning recommendations.

Against the July 2026 baseline, Fountain TRT declined 2.3 points in valid recommendation coverage, from 11.0% to 8.72%. This movement stayed within normal month-to-month variation, but it places the brand in the middle of a category where the top two competitors, Hone Health and Defy Medical, hold coverage rates above 40%.

What Fountain TRT Is Winning

Questions This Section Answers

• Where does Fountain TRT's sentiment position it relative to other TRT clinics?
• Which platforms show the strongest recommendation placement signals for Fountain TRT?

Fountain TRT's clearest win is its positive sentiment profile. With 20 positive mentions and zero negative mentions across 31 total appearances, the brand benefits from favorable framing whenever AI systems surface it. A net sentiment score of 0.6452 places it ahead of Renew Vitality (0.4615) and Low T Center (0.2667), though behind leaders like Defy Medical (0.9135) and Maximus (0.875).

The brand also holds a meaningful position on Google AI Mode, where it earned 7 valid recommendations and a positive visibility rate of 12.3%. This platform represents the largest single opportunity pool in the benchmark, and Fountain TRT's presence there is a foundation to build on.

On Copilot, Fountain TRT recorded 7 valid recommendations with a top-three rate of 10.3% and a rank-one rate of 3.4%. This is the brand's strongest placement signal across any platform, suggesting that Copilot's answer structure is more receptive to Fountain TRT's current evidence footprint.

Where Fountain TRT Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why is Fountain TRT mentioned in AI answers but rarely recommended as a TRT clinic option?
• Which AI platforms show the most significant absence of Fountain TRT recommendations?
• How far behind are Fountain TRT's rank-one recommendations compared to leading competitors?

Fountain TRT's most significant gap is the distance between presence and recommendation. The brand appears in 14.22% of qualified observations but earns valid recommendations in only 8.72%. This means that in roughly 4 out of every 10 answers where Fountain TRT is mentioned, it is referenced as context rather than recommended as a shortlist option.

The brand's rank-one rate of 0.46% is the clearest indicator of under-conversion. Across 218 qualified observations, Fountain TRT was positioned as the first recommendation just once. Competitors like Maximus (9.63%), Hone Health (8.26%), and Defy Medical (3.67%) capture first-position recommendations at rates that are 8 to 21 times higher.

On Gemini, Fountain TRT recorded 3 context-only mentions across 20 observations and zero valid recommendations. This absence is notable because Gemini represents a distinct surface where competitors like Maximus and Defy Medical each hold a 65.0% presence rate and are actively earning recommendations. Fountain TRT's lack of recommendation-level presence on Gemini suggests that the brand's public evidence layer may not be structured in a way that Gemini's retrieval and synthesis processes can surface.

Perplexity shows a similar pattern: 2 positive mentions across 6 observations but no recommendation-level conversion. While the observation count is smaller, the pattern is consistent with the Gemini gap and points to a broader issue in how Fountain TRT's evidence footprint is distributed across platforms.

On ChatGPT, Fountain TRT recorded zero mentions across 12 observations. This is a significant gap given that ChatGPT is one of the most widely used AI platforms for buyer research. Competitors like Hone Health (83.3% presence rate) and Defy Medical (66.7% presence rate) are highly visible on this surface, while Fountain TRT is entirely absent.

Biggest Opportunity

Questions This Section Answers

• Which platforms offer the clearest opportunity to convert Fountain TRT's existing presence into higher placement rates?
• What evidence sources should Fountain TRT strengthen so AI systems can easily extract and cite them in TRT clinic recommendations?

Fountain TRT's biggest opportunity is converting its existing presence on Google AI Mode and Copilot into higher placement rates. The brand already earns valid recommendations on these platforms, but its top-three and rank-one rates lag significantly behind competitors. On Google AI Mode, Fountain TRT holds a top-three rate of 1.8% and a rank-one rate of 0.0%, despite earning 7 valid recommendations. On Copilot, the top-three rate is 10.3% and the rank-one rate is 3.4%, showing stronger placement but still trailing Maximus (44.8% top-three rate on Copilot).

The path forward is to strengthen the evidence sources that AI systems retrieve when constructing recommendation shortlists. This means ensuring that Fountain TRT's clinical credentials, patient outcomes, pricing transparency, and third-party validation are structured in ways that AI systems can easily extract and cite. The brand's positive sentiment profile provides a foundation; the next step is making that positivity actionable in shortlist contexts.

Competitive Landscape

Questions This Section Answers

• How does Fountain TRT's recommendation coverage and placement compare to Hone Health, Defy Medical, and Maximus?
• Which TRT clinics lead in top-three and rank-one recommendation rates?

Hone Health and Defy Medical hold dominant recommendation-stage strength in the TRT Clinics category, with valid recommendation coverage rates of 42.7% and 40.8% respectively. Maximus follows as the strongest challenger at 27.5%, while Fountain TRT sits in sixth position at 8.72%, well behind the leader tier.

Average recommended rank covers rank-eligible recommendations only.

Fountain TRT's position in the table reflects its current standing: sixth in top-three rate, tied for sixth in rank-one rate, and sixth in average recommended rank. The brand's sentiment score is competitive with mid-tier competitors, but its placement metrics lag significantly behind the top four brands.

Prompt Evidence

Questions This Section Answers

• What did AI platforms actually show when buyers asked for the best TRT clinics or online testosterone providers?
• Which specific prompts revealed Fountain TRT's absence from AI recommendations?

Google AI Mode / Best TRT Clinics & Top Testosterone Therapy Providers Prompt: "best testosterone replacement therapy" Result: Fountain TRT appeared in the answer with positive framing but was not positioned among the top three recommendations.

Copilot / Best TRT Clinics & Top Testosterone Therapy Providers Prompt: "online doctors that prescribe testosterone" Result: Fountain TRT earned a valid recommendation with a top-three placement, one of the brand's strongest showings on this platform.

ChatGPT / Best TRT Clinics & Top Testosterone Therapy Providers Prompt: "trt clinic" Result: Fountain TRT did not appear in the response, while competitors like Hone Health and Defy Medical were recommended.

Gemini / Best TRT Clinics & Top Testosterone Therapy Providers Prompt: "best trt online" Result: Fountain TRT recorded zero mentions, indicating a complete absence from Gemini's recommendation set for this prompt.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map every prompt where Fountain TRT appears, is mentioned without recommendation, or is entirely absent, and identify the specific evidence gaps that explain each outcome.

Phase 2: Recommendation Readiness Plan Prioritize the platforms and prompt clusters where Fountain TRT's presence is strongest but conversion is weakest, starting with Google AI Mode and Copilot.

Phase 3: Owned Answer Layer Buildout Develop structured, extractable content that directly addresses the questions AI systems ask when constructing TRT clinic recommendations, including clinical credentials, pricing transparency, and patient outcomes.

Phase 4: Citation / Authority Layer Development Strengthen the third-party sources, reviews, and authoritative references that AI systems retrieve when validating clinic recommendations, with emphasis on sources that Gemini and ChatGPT are likely to surface.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Fountain TRT's presence, recommendation coverage, top-three rate, and rank-one rate across all six platforms to measure progress and adjust strategy as the category evolves.

Why This Matters

AI systems are increasingly where buyers form their shortlists. When someone asks ChatGPT, Gemini, or Google AI Mode for the best TRT clinic, the answer they receive shapes their consideration set before they ever visit a website or speak to a provider. Fountain TRT's current position, visible but under-recommended, means the brand is being seen but not chosen at the moment that matters most.

The gap between presence and recommendation is not a visibility problem; it is a conversion problem. Fountain TRT appears in AI answers at a rate that suggests the brand has a meaningful public evidence layer. But that evidence is not structured in a way that AI systems can easily convert into shortlist-level recommendations. Closing this gap requires targeted work on the prompt, page, and citation layers that AI systems use to construct their answers.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Fountain TRT in September 2026: (20 × 1 + 11 × 0 + 0 × -1) / 31 = 0.6452

This score matters because unclassified mention counts are misleading. A brand that appears frequently but is only referenced as context, or worse, as a cautionary example, is not in the same position as a brand that is actively recommended. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal.

Counting all mentions as wins is bad measurement. Fountain TRT's 31 mentions include 11 neutral references where the brand was mentioned but not recommended. If those were counted as wins, the brand's position would appear stronger than it is. Classified sentiment is required before interpreting AI visibility, because only then can a brand understand whether it is being recommended, referenced, or overlooked.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Fountain TRT's position in the TRT Clinics category, using data from the LLM Authority Index AI Market Discovery Index for September 2026.
2. The reporting window is September 2026, with comparison points at July 2026 (baseline) and August 2026 (intermediate month).
3. Six AI and search surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode.
4. The September 2026 benchmark produced 218 qualified observations from an initial collection of 800 prompt-surface observations.
5. The competitor universe includes 10 tracked brands: BioTE, Craft Concierge, Defy Medical, Fountain TRT, Henry Meds, Hone Health, Low T Center, Marek Health, Maximus, and Renew Vitality.
6. Three public high-intent clusters were defined: C01 (Best TRT Clinics & Top Testosterone Therapy Providers), C02 (TRT Clinic Comparisons & Testosterone Therapy Alternatives), and C03 (TRT Clinic Pricing, Cost & Affordability). Only C01 contained qualified observations in the current public series.
7. Stage 0 extraction retained the query, AI surface, answer, brand outcome, recommendation placement, sentiment, and citations where exposed.
8. A mention is defined as any appearance of Fountain TRT in a qualified AI response, regardless of whether the brand was recommended.
9. A valid recommendation is defined as a clear, actionable recommendation of Fountain TRT as a TRT clinic option, distinct from neutral references or contextual mentions.
10. Ranking interpretation: top-three rate measures how often Fountain TRT appeared among the first three recommendations; rank-one rate measures how often it was the first recommendation; average recommended rank covers rank-eligible recommendations only.
11. Limitations: The public benchmark does not measure market share, attributable sales, every possible AI response, organic-search ranking, social mention volume, or private or sponsored channels. A metric movement alone does not establish causality. Small-count brands like Fountain TRT operate on fewer than 20 valid recommendations, so a change of one or two answers can materially move percentages.
12. Dataset note: The public percentages use the 218 qualified observations as the denominator, not the 800 raw prompt-surface observations collected.

See Where AI Is Recommending Your Brand

Fountain TRT's position in AI recommendations is measurable, trackable, and improvable. A company-level AI visibility audit maps the specific prompts, platforms, and evidence sources that shape how AI systems recommend TRT clinics, and identifies the highest-priority actions to close the gap between presence and recommendation.